Gold, M. R., Siegel, J. E., Russell, L. B. and Weinstein, M. C. (1996) Cost-effectiveness in health and medicine, Oxford University Press.
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., et al. (2013) 'Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement', BMJ : British Medical Journal, 346.
Neumann, P. J., Stone, P. W., Chapman, R. H., Sandberg, E. A. and Bell, C. M. (2000) 'The quality of reporting in published cost-utility analyses, 1976–1997', Annals of Internal Medicine, 132(12), 964-972.
Pharmaceutical Benefits Advisory Committee (2016) Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (version 5.0), Australian Government Department of Health.
Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., et al. (2015) 'Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report', Value in Health, 18(2), 161-172.
Sullivan, S. M., Wells, G. and Coyle, D. (2015) 'What Guidance are Economists Given on How to Present Economic Evaluations for Policymakers? A Systematic Review', Value Health, 18(6), 915-24.
Thai Health Technology Assessment Guideline Working Group (2008) 'Guidelines for Health Technology Assessment in Thailand (First Edition)'.